Recent NHTA courses and seminars

In NHTA we are busier than ever. However, when we have the time, we love conducting educational courses and engaging in the interesting discussions these bring.

In October & November 2021 NHTA had the pleasure of presenting and offering educational courses at Aalborg University, Atrium, and Medicoindustrien (The Danish MedTech trade association).   

At Aalborg University Asger Lindvig and Matilde Faller delivered a 3-days Excel modeling course for students of 9th semester of Medical Market Access and 9th semester of Public Health Science with interest in health economics. In the course, Asger and Matilde covered basics health economics, providing the students with a basic understanding of excel health economic modelling, including:  

  • Basic Excel functions  
  • Health economic principles, such as ICER and NMB 
  • Different health economic analyses and models 
  • Survival analysis and its importance in health economics 
  • Sensitivity analysis and its application in excel  
  • Introduction to Excel’s computer programming language, VBA (Visual Basic for Applications)  

Anders Mærkedahl, was also invited by Aalborg University to teach students at 7th semester of Medical Market Access in the module “Market Access for Healthcare for Medtech”. Here, Anders gave an insight into concepts and processes of MedTech market access and how these differ from Pharmaceuticals, including: 

  • The why, when and how both health economics and Market Access strategy should play an important role throughout the Product life cycle 
  • MedTech reimbursement 
  • Introduction to Health Technology Assessment (HTA) within MedTech 

Furthermore, Anders delivered a course at Medicoindustrienintroducing the principles of Health Economics evaluationsprinciples and processes within Market Access with a particular focus on payer evidence requirements and potential strategies.  

Lastly, Asger Lindvig delivered a module for the course “Cross-functional Market Access” provided by Atrium. Here, Asger provided in-depth insight into Market Access for hospital medicines in Denmark. The course included knowledge in The Danish Medicines Council process, including:  

  • The requirements 
  • The impact of the new assessment framework and the QALY 
  • The clinical documentation and health economic analyses 
  • Pricing and innovative agreement structures 
  • Negotiation, tactics, and tool 
  • The learnings so far of using the new DMC model 

Thank you all for inviting us and for all who have participated in the courses.  

Menu